Andrew M. Luks

ORCID: 0000-0003-1438-7464
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • High Altitude and Hypoxia
  • Travel-related health issues
  • Neuroscience of respiration and sleep
  • Climate Change and Health Impacts
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Cardiac Arrest and Resuscitation
  • Innovations in Medical Education
  • Cardiovascular and exercise physiology
  • Heart Rate Variability and Autonomic Control
  • Intensive Care Unit Cognitive Disorders
  • Clinical Reasoning and Diagnostic Skills
  • Anesthesia and Sedative Agents
  • Heme Oxygenase-1 and Carbon Monoxide
  • Renal function and acid-base balance
  • Hemodynamic Monitoring and Therapy
  • Non-Invasive Vital Sign Monitoring
  • Cardiovascular and Diving-Related Complications
  • Mechanical Circulatory Support Devices
  • Thermal Regulation in Medicine
  • Sepsis Diagnosis and Treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • Electrolyte and hormonal disorders
  • Cardiovascular Effects of Exercise
  • Anesthesia and Pain Management

University of Washington
2016-2025

Harborview Medical Center
2012-2025

Pulmonary and Critical Care Associates
2016-2020

SleepMed
2020

Seattle University
2007-2020

Fred Hutch Cancer Center
2020

Virginia Mason Medical Center
2020

Swedish Medical Center
2020

St. Paul's Hospital
2020

Imperial College London
2020

Community transmission of coronavirus 2019 (Covid-19) was detected in the state Washington February 2020. We identified patients from nine Seattle-area hospitals who were admitted to intensive care unit (ICU) with confirmed infection severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Clinical data obtained through review medical records. The reported here are those available March 23, Each patient had at least 14 days follow-up. 24 Covid-19. mean (±SD) age 64±18 years, 63% men,...

10.1056/nejmoa2004500 article EN New England Journal of Medicine 2020-03-30
Robert C. Roach Peter H. Hackett O Oelz Peter Bärtsch Andrew M. Luks and 87 more Martin J. MacInnis J. Kenneth Baillie Eric Achatz Edi Albert J. Andrews James D. Anholm Mohammad Zahid Ashraf Paul S. Auerbach Buddha Basnyat Beth A. Beidleman Remco R. Berendsen Marc Moritz Berger Konrad E. Bloch Hermann Brugger Annalisa Cogo Ricardo Gonzalez Costa Andrew F. Cumpstey Allen Cymerman Tadej Debevec Catriona Duncan David J. Dubowitz Angela Fago Michaël Furian Matt Gaidica Prosenjit Ganguli Michael P. W. Grocott Debra Hammer David P. Hall David Hillebrandt Matthias P. Hilty Gigugu Himashree Benjamin Honigman Ned Gilbert-Kawai Bengt Kayser Linda E. Keyes Michael S. Koehle Samantha Kohli Arlena Kuenzel Benjamin D. Levine Mona Lichtblau Jamie Macdonald Monika Brodmann Maeder Marco Maggiorini Daniel Martín Shigeru Masuyama John McCall Scott McIntosh Grégoire P. Millet Fernando A. Moraga Craig Mounsey Stephen R. Muza Samuel J. Oliver Qadar Pasha Ryan F. Paterson Lara Phillips Aurélien Pichon Philipp A. Pickerodt Matiram Pun Manjari Rain Drummond Rennie Ri‐Li Ge Steven Roy Samuel Vergès Tatiana Batalha Cunha dos Santos Robert B. Schoene Otto D. Schoch SP Singh Talant Sooronbaev Craig D. Steinback Mike Stembridge Glenn M. Stewart Tsering Stobdan Giacomo Strapazzon Andrew W. Subudhi Erik R. Swenson A. A. Roger Thompson Martha C. Tissot van Patot Rosie Twomey Silvia Ulrich Nicolas Voituron Dale R. Wagner Shih-hao Wang John B. West Matt Wilkes Gabriel Willmann Michael Yaron Ken Zafren

Roach, Robert C., Peter H. Hackett, Oswald Oelz, Bärtsch, Andrew M. Luks, Martin J. MacInnis, Kenneth Baillie, and The Lake Louise AMS Score Consensus Committee. 2018 Acute Mountain Sickness Score. High Alt Med Biol 19:1-4, 2018.- (AMS) scoring system has been a useful research tool since first published in 1991. Recent studies have shown that disturbed sleep at altitude, one of the five symptoms scored for AMS, is more likely due to altitude hypoxia per se, not closely related AMS. To...

10.1089/ham.2017.0164 article EN High Altitude Medicine & Biology 2018-03-01

Rationale: No direct comparisons of clinical features, laboratory values, and outcomes between critically ill patients with coronavirus disease (COVID-19) influenza in the United States have been reported.Objectives: To evaluate risk mortality comparing COVID-19 seasonal influenza.Methods: We retrospectively identified admitted to intensive care units (ICUs) at two academic medical centers laboratory-confirmed severe acute respiratory syndrome 2 (SARS-CoV-2) or A B infections January 1,...

10.1513/annalsats.202007-805oc article EN cc-by-nc-nd Annals of the American Thoracic Society 2020-11-13

Basnyat Buddha, Jeffrey H. Gertsch, Peter S. Holck, E. William Johnson, Andrew M. Luks, Benjamin P. Donham, Ross J. Fleischman, Daniel W. Gowder, Jason Hawksworth, Brett T. Jensen, Richard Kleiman, Adam Loveridge, Elizabeth B. Lundeen, Sheri L. Newman, Jesse A. Noboa, Miegs, Kenneth O'Beirne, Kelly Philpot, Miriam N. Schultz, Matthew C. Valente, Mandie R. Wiebers, and Erik Swenson. Acetazolamide 125 mg BD is not significantly different from 375 in the prevention of acute mountain sickness:...

10.1089/ham.2006.7.17 article EN High Altitude Medicine & Biology 2006-03-01

High altitude (HA)-induced pulmonary hypertension may be due to a free radical-mediated reduction in nitric oxide (NO) bioavailability. We hypothesised that the increase artery systolic pressure (PASP) at HA would associated with net transpulmonary output of radicals and corresponding loss bioactive NO metabolites. Twenty-six mountaineers provided central venous radial arterial samples low (LA) following active ascent 4559 m (HA). PASP was determined by Doppler echocardiography, blood flow...

10.1113/jphysiol.2010.194704 article EN The Journal of Physiology 2010-09-28
Coming Soon ...